Harrow (HROW) Income from Continuing Operations (2010 - 2026)

Harrow (HROW) recorded quarterly Income from Continuing Operations of 27602000.0 in Q1 2026, down 365.48% quarter-over-quarter from 10397000.0 in Q4 2025, and down 55.24% on a YoY basis from 61669208.34 in Q1 2025.

Harrow (HROW) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Harrow's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 27602000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 55.24% year-over-year to 27602000.0; the TTM figure through Mar 2026 stood at 11190000.0 (up 48.42% YoY), while the FY2025 annual figure was 5139000.0, up 70.6% from the prior year.
  • Income from Continuing Operations was 27602000.0 for Q1 2026 at Harrow, down from 10397000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10397000.0 in Q4 2025 to a low of 27602000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 4996941.18 across 5 years, with a median of 4391000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations plunged 1223.5% in 2022, then soared 177.17% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 1055000.0 in 2022, then slumped by 967.11% to 9148000.0 in 2023, then surged by 174.08% to 6777000.0 in 2024, then surged by 53.42% to 10397000.0 in 2025, then slumped by 365.48% to 27602000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 27602000.0 (Q1 2026), 10397000.0 (Q4 2025), and 1020000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn -27.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -27.60 Mn
Dec 31, 2025 10.40 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -13.57 Mn
Dec 31, 2023 -9.15 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -6.64 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 -6.24 Mn
Mar 31, 2022 -2.44 Mn
Dec 31, 2021 -7.29 Mn
Sep 30, 2021 -8.33 Mn
Jun 30, 2021 -2.48 Mn